A ligand’s-eye view of protein binding
暂无分享,去创建一个
[1] Paul J Lewi,et al. Structure based activity prediction of HIV-1 reverse transcriptase inhibitors. , 2005, Journal of medicinal chemistry.
[2] R. Clark,et al. Consensus scoring for ligand/protein interactions. , 2002, Journal of molecular graphics & modelling.
[3] G Klebe,et al. On the prediction of binding properties of drug molecules by comparative molecular field analysis. , 1993, Journal of medicinal chemistry.
[4] Ronan Bureau,et al. Comparative molecular field analysis of CCK-A antagonists using field-fit as an alignment technique. A convenient guide to design new CCK-A ligands , 1992, J. Comput. Aided Mol. Des..
[5] Ki Hwan Kim,et al. Outliers in SAR and QSAR: Is unusual binding mode a possible source of outliers? , 2007, J. Comput. Aided Mol. Des..
[6] Ingo Muegge,et al. 3D-Quantitative Structure Activity Relationships of Biphenyl Carboxylic Acid MMP-3 Inhibitors: Exploring Automated Docking as Alignment Method , 2001 .
[7] Márcia M. C. Ferreira,et al. A structure–activity relationship study of HEPT-analog compounds with anti-HIV activity , 2000 .
[8] Zhigang Zhou,et al. CoMFA 3D-QSAR Analysis of HIV-1 RT Nonnucleoside Inhibitors, TIBO Derivatives Based on Docking Conformation and Alignment , 2004, J. Chem. Inf. Model..
[9] David A. Frenkel,et al. CoMFA validation of the superposition of six classes of compounds which block GABA receptors non-competitively , 1993, J. Comput. Aided Mol. Des..
[10] Matthew Clark,et al. The Probability of Chance Correlation Using Partial Least Squares (PLS) , 1993 .
[11] Carmen Almansa,et al. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site? , 2003, Journal of medicinal chemistry.
[12] Ajay N. Jain. Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search , 2007, J. Comput. Aided Mol. Des..
[13] Juan M. Luco,et al. QSAR Based on Multiple Linear Regression and PLS Methods for the Anti-HIV Activity of a Large Group of HEPT Derivatives , 1997, J. Chem. Inf. Comput. Sci..
[14] H. Kubinyi,et al. 3D QSAR in drug design. , 2002 .
[15] Anderson Coser Gaudio,et al. HEPT derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase: QSAR studies agree with the crystal structures , 2002, J. Comput. Aided Mol. Des..
[16] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[17] D. Lesieur,et al. Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis. , 2001, Journal of medicinal chemistry.
[18] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[19] C. Monneret,et al. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition. , 1997, Journal of medicinal chemistry.
[20] R. Kurumbail,et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents , 1996, Nature.
[21] Jonas Boström,et al. Conformational energy penalties of protein-bound ligands , 1998, J. Comput. Aided Mol. Des..
[22] T. Steitz,et al. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. , 1992, Science.
[23] Richard T. Walker,et al. Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. , 1996, Journal of medicinal chemistry.
[24] S Shigeta,et al. A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). , 1991, Journal of medicinal chemistry.
[25] Peter C. Fox,et al. Statistical variation in progressive scrambling , 2004, J. Comput. Aided Mol. Des..
[26] Juan J Perez,et al. Differential binding mode of diverse cyclooxygenase inhibitors. , 2002, Journal of molecular graphics & modelling.
[27] Asit K Chakraborti,et al. Computer-aided design of non sulphonyl COX-2 inhibitors: an improved comparative molecular field analysis incorporating additional descriptors and comparative molecular similarity indices analysis of 1,3-diarylisoindole derivatives. , 2003, Bioorganic & medicinal chemistry.
[28] P. Charifson,et al. Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding. , 2004, Journal of medicinal chemistry.
[29] Yvonne C. Martin,et al. 3D QSAR: current state, scope, and limitations , 1998 .
[30] Supa Hannongbua,et al. 3D-Quantitative Structure-Activity Relationships of HEPT Derivatives as HIV-1 Reverse Transcriptase Inhibitors, Based on Ab Initio Calculations , 2001, J. Chem. Inf. Comput. Sci..
[31] G. Klebe,et al. DrugScore meets CoMFA: adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein. , 2002, Journal of medicinal chemistry.
[32] D I Stuart,et al. Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants. , 1999, Journal of medicinal chemistry.
[33] Gregory W. Kauffman,et al. QSAR and k-Nearest Neighbor Classification Analysis of Selective Cyclooxygenase-2 Inhibitors Using Topologically-Based Numerical Descriptors , 2001, J. Chem. Inf. Comput. Sci..
[34] R. Webster Homer,et al. SYBYL Line Notation (SLN): A Versatile Language for Chemical Structure Representation , 1997, J. Chem. Inf. Comput. Sci..
[35] D. Lesieur,et al. Comparative Molecular Field Analysis of Selective Cyclooxygenase‐2 (COX‐2) Inhibitors , 2000 .
[36] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[37] R. Pouplana,et al. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs , 2002, J. Comput. Aided Mol. Des..
[38] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[39] Luc Morin-Allory,et al. 2D QSAR Consensus Prediction for High-Throughput Virtual Screening. An Application to COX-2 Inhibition Modeling and Screening of the NCI Database , 2004, J. Chem. Inf. Model..
[40] P. Carrupt,et al. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .
[41] Bart De Corte,et al. From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125): fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2005 .
[42] Gerhard Klebe,et al. Different approaches toward an automatic structural alignment of drug molecules: Applications to sterol mimics, thrombin and thermolysin inhibitors , 1994, J. Comput. Aided Mol. Des..
[43] E. Coutinho,et al. A CoMFA study of COX-2 inhibitors with receptor based alignment. , 2004, Journal of molecular graphics & modelling.
[44] Gautam R. Desiraju,et al. Computer-aided design of selective cox-2 inhibitors: comparative molecular field analysis and docking studies of some 3,4-diaryloxazolone derivatives , 2001 .
[45] R. Cramer,et al. Topomer CoMFA: a design methodology for rapid lead optimization. , 2003, Journal of medicinal chemistry.
[46] Tudor I. Oprea,et al. Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes. , 1994, Journal of medicinal chemistry.
[47] Jonas Boström,et al. Reproducing the conformations of protein-bound ligands: A critical evaluation of several popular conformational searching tools , 2001, J. Comput. Aided Mol. Des..
[48] Thierry Langer,et al. On the Use of Chemical Function-Based Alignments as Input for 3D-QSAR , 1998, J. Chem. Inf. Comput. Sci..
[49] Shashidhar N. Rao,et al. Partially Unified Multiple Property Recursive Partitioning (PUMP-RP) Analyses of Cyclooxygenase (COX) Inhibitors , 2003, J. Chem. Inf. Comput. Sci..
[50] R T Walker,et al. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity. , 1992, Journal of medicinal chemistry.
[51] Erik De Clercq,et al. Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future , 2004, Chemistry & biodiversity.
[52] A. M. Myers,et al. Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. , 1994, Journal of medicinal chemistry.
[53] Tudor I. Oprea,et al. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules. , 1993, Journal of medicinal chemistry.
[54] Garland R. Marshall,et al. 3D-QSAR of angiotensin-converting enzyme and thermolysin inhibitors: A comparison of CoMFA models based on deduced and experimentally determined active site geometries , 1993 .
[55] A Tropsha,et al. Cross-validated R2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. , 1995, Journal of medicinal chemistry.
[56] Ajay N. Jain. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.
[57] Mehdi Jalali-Heravi,et al. Use of Artificial Neural Networks in a QSAR Study of Anti-HIV Activity for a Large Group of HEPT Derivatives , 2000, J. Chem. Inf. Comput. Sci..
[58] Robert D. Clark,et al. Boosted leave-many-out cross-validation: the effect of training and test set diversity on PLS statistics , 2003, J. Comput. Aided Mol. Des..
[59] José L. Medina-Franco,et al. Docking-based CoMFA and CoMSIA studies of non-nucleoside reverse transcriptase inhibitors of the pyridinone derivative type , 2004, J. Comput. Aided Mol. Des..
[60] Osman F. Güner,et al. Pharmacophore perception, development, and use in drug design , 2000 .
[61] Ruisheng Zhang,et al. QSAR and classification models of a novel series of COX-2 selective inhibitors: 1, 5-diarylimidazoles based on support vector machines , 2004, J. Comput. Aided Mol. Des..
[62] Sivaprakasam Prasanna,et al. QSAR Analysis of 2,3‐Diaryl Benzopyrans/Pyrans as Selective COX‐2 Inhibitors Based on Semiempirical AM1 Calculations , 2004 .